Historically, botanical preparations have been used to improve human health. Their active ingredients are influenced by multiple factors as intraspecies variations, environmental conditions, collection time and methods and the part of the plant used. To ensure the efficiency and safety of these herbal drugs, qualitative and quantitative analyses are required. Tessaria absinthioides decoction (DETa) was reported as hypocholesterolemic, anti-inflammatory, cytotoxic, antitumor, and antioxidant. This work aimed to analyze DETa, by correlating its chemical composition with cytotoxic and antioxidant properties, to promote its research as an anticancer agent. DETa collections (2017, 2018, 2019 and 2022) were analyzed by UHPLC-UV-Vis, UHPLC-DAD-FLD and UPLC-MS/MS; cytotoxicity was assessed on the MCF-7 breast cancer cell line, and antioxidant capacity was evaluated by DPPH and FRAP methods; correlation analysis was used to determine biological and chemical markers. The results evidence that biological activities were consistent across collections. Among the quantified compounds, apigenin, naringin, gallocatechin gallate, ginnalin A, myricetin, epicatechin, OH-tyrosol, quercetin, and chlorogenic, tessaric, p-coumaric, vanillic, caffeic, caftaric, ellagic and rosmarinic acids correlated as bioactive and chemical markers. Moreover, tessaric acid could be established as a species marker. Altogether, these findings add relevant information to DETa properties encouraging further exploration of its potential application as anticancer botanical.

Historically, botanical preparations have been used to improve human health. Their active ingredients are influenced by multiple factors such as intraspecies variations, environmental conditions, collection time and methods, and the part of the plant used. To ensure the efficiency and safety of these herbal drugs, qualitative and quantitative analyses are required. A Tessaria absinthioides decoction (DETa) was reported as having hypocholesterolemic, anti-inflammatory, cytotoxic, antitumor, and antioxidative properties. This work aimed to analyze DETa by correlating its chemical composition with cytotoxic and antioxidative properties, with the aim of promoting research on it as an anticancer agent. DETa collections (2017, 2018, 2019, and 2022) were analyzed by UHPLC-DAD, UHPLC-DAD-FLD, and UPLC-MS/MS; cytotoxicity was assessed on the MCF-7 breast cancer cell line; antioxidative capacity was evaluated by the DPPH and FRAP methods; and correlation analysis was used to determine biological and chemical markers. The results provide evidence that biological activities were consistent across the collections. Among the quantified compounds, apigenin, naringin, gallocatechin gallate, ginnalin A, myricetin, epicatechin, OH-tyrosol, quercetin, and chlorogenic, tessaric, p-coumaric, vanillic, caffeic, caftaric, ellagic, and rosmarinic acids correlated as bioactive and chemical markers. Moreover, tessaric acid could be established as a species marker. Altogether, these findings add relevant information to DETa properties, encouraging further exploration of its potential application as an anticancer botanical.

New products with tolerogenic properties on T cell response are necessary to improve current efficacy, cost and side effects of immunosuppressants. Prosopis strombulifera aqueous extract (PsAE) have reported cytotoxic, antitumoral, antiatherogenic and antileishmanial activities, containing phytochemicals with immune-related activities. Despite these, there are no previous studies with respect to PsAE suppressive properties over T cell proliferation and their function. Because of previous antecedents, this study aims to evaluate the effect of PsAE on T cell activation, proliferation, cytokine production, and to investigate its effect over an in vivo model of type 1 diabetes (T1D). Splenocytes and sorted CD4⁺/CD8⁺ from wild type C57BL/6 mice were cultured to determine activation, IFN-γ release and T-cell proliferation after polyclonal stimulation. NOD (non-obese diabetic) mice were used to study the effects of orally administered extract on glycemia, insulitis stages and perforin-1 (PRF-1)/granzyme-B (GRZ-B) expression. In primary cultures, the plant extract impairs T cell activation, decreases IFN-γ release, and reduces proliferation after different polyclonal stimuli. In vivo, PsAE improves NOD mice glycemic levels and T1D progression by diminution of pancreas insulitis and reduction of PRF-1 and GRZ-B mRNA expression. To our knowledge, this is the first report characterizing the therapeutic properties of PsAE on T cell activation. The current work provides evidence about in vitro and in vivo immunosuppressive effects of PsAE and promotes this plant extract as a complementary and alternative treatment in autoimmune T-cell mediated diseases as T1D.

Melanoma is one of the deathliest cancers worldwide and its incidence is reaching epidemic proportions. It is characterized by intrinsic chemo-resistance, low response rates to treatment and high metastatic potential. Because of this, new therapeutic options are permanently required. Tessaria absinthioides (Hook. & Arn.) DC. is a traditional medicinal plant, with antioxidant, selective cytotoxicity and anti-colorectal cancer evidence-based properties. This study aims to demonstrate the antitumoral and antimetastatic effects of T. absinthioides decoction (DETa), correlating in vitro and in vivo activities in a murine melanoma model. DETa was assayed on B16F0 murine non-metastatic cells to determine cytotoxicity and clonogenicity; while, in the B16F10 metastatic siblings, adhesion, wound healing migration and Boyden chamber invasion were studied. The ex vivo intestinal-sac model was used to quantify DETa bioavailability. Meanwhile, in C57BL6/wt mice, DETa was orally administered to evaluate its antitumoral and antimetastatic activities. DETa induced cytotoxicity in a dose- and time-dependent manner, affecting the long-term clonogenic survival, as well as the processes of adhesion and migration. Then, the intestinal absorption of DETa phenolics was proven, while the systemic anti-tumoral and anti-metastatic activities of DETa were confirmed. Results demonstrated that DETa has antimelanoma activity promoting this botanical compound as a relevant agent for cancer research and treatment.

Oxalis corniculata L. is an ethnobotanically recognized plant in Ecuador. Although its bioactive extracts have been investigated, the chemical and biological properties of its essential oil (OcEO) remain unexplored. This study aimed to characterize the chemical profile of OcEO and evaluate its in vitro antioxidant, antimicrobial, and cytotoxic properties. Aerial parts of O. corniculata were collected and hydrodistilled to obtain the OcEO. Its phytochemical profile was characterized using GC-MS and GC-FID. Antioxidant capacity was measured via DPPH, ABTS, and FRAP assays. Antimicrobial activity against Klebsiella pneumoniae, Acinetobacter baumannii, and Candida albicans was evaluated by determining the minimum inhibitory concentration (MIC) and zone of inhibition (ZOI). Cytotoxicity was assessed on MCF-7, HCT-116, and MRC-5 cell lines using the MTT assay, determining the IC₅₀ and Selective Cytotoxicity Index (SCI). The GC-MS and GC-FID analysis identified or tentatively identified 24 constituents (accounting for 93.2% of the total oil composition), predominantly sesquiterpenes (54.96%), with β-caryophyllene (24.71%) and germacrene D (14.62%) as the major components. OcEO showed moderate complementary chemical antioxidant and antimicrobial effects, being most active against K. pneumoniae (MIC: 0.56 mg/mL) and C. albicans (MIC: 2.24 mg/mL). Furthermore, OcEO evidenced selective cytotoxicity against tumor cells, particularly against HCT-116 (IC₅₀: 8.19 mg/mL; SCI: 4.52). In conclusion, OcEO exhibits potential in vitro antioxidant, antimicrobial, and cytotoxic properties, providing preliminary evidence to support future research on this Ecuadorian essential oil.